Mifegyne (mifepristone), a new antiprogestagen with potential therapeutic use in human fertility control.
作者:
B,Couzinet [1]
;
G,Schaison
作者单位:
Service d'Endocrinologie et des Maladies de la Reproduction, Hôpital Bicêtre.
[1]
期刊:
《Drugs》
1988年35卷3期187-91页
关键词:
Abortion, Drug Induced;Abortion, Induced;Animals, Laboratory;Biology;Bleeding;Clinical Research;Contraception;Contraception Research;Diseases;Endocrine System;Endometrial Effects;Endometrium;Family Planning;Fertility Control, Postconception;Genitalia;Genitalia, Female;Hormone Antagonists;Hormones;Human Volunteers;Literature Review;Myometrial Effects;Myometrium;Physiology;Research Methodology;Research Report;Ru-486;Signs And Symptoms;Urogenital System;Uterus;Vacuum Aspiration
主题词:
堕胎药(Abortifacient Agents);堕胎药, 甾类(Abortifacient Agents, Steroidal);避孕药, 口服, 合成(Contraceptives, Oral, Synthetic);雌烯类(Estrenes);女(雌)性(Female);人类(Humans);引产(Labor, Induced);米非司酮(Mifepristone);妊娠(Pregnancy);受体, 孕酮(Receptors, Progesterone)
DOI:
10.2165/00003495-198835030-00001
PMID:
3286211
发布时间:
2018-11-13
- 翻译满意度评价:
- 提交
- 浏览:83
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文